SCHEMBL3984246

SCHEMBL3984246

[C]OCC[Si](C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7081970 0.72
SCHEMBL430949 0.72
SCHEMBL1289421 0.69 MEN1 (0.32)
SCHEMBL8009 0.69
SCHEMBL419805 0.69 MEN1 (0.32)
SCHEMBL7081966 0.67
SCHEMBL8008 0.67
Ammonia Solution, Strong SCHEMBL16110998 0.67
SCHEMBL6847438 0.67
SCHEMBL12687036 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2032530-A1 PYRROLIDINE COMPOUNDS AS RENIN INHIBITORS Novartis AG (CH) 2009-03-11 EP disclosed
EP-1940789-A1 METHODS AND COMPOUNDS FOR PREPARING CC-1065 ANALOGS Medarex, Inc. (US) 2008-07-09 EP disclosed
WO-2007144128-A1 PYRROLIDINE COMPOUNDS AS RENIN INHIBITORS NOVARTIS AG (CH) 2007-12-21 WO disclosed
WO-2007051081-A1 METHODS AND COMPOUNDS FOR PREPARING CC-1065 ANALOGS MEDAREX, INC. (US) 2007-05-03 WO disclosed
EP-0258183-A2 Process for the preparation of 5-amino-4-hydroxyvaleric-acid derivatives CIBA-GEIGY AG (CH) 1988-03-02 EP disclosed